Zhu Bisheng agreed to acquire 10% stake in Nanjing Reseader Medical Technology Co., Ltd. from Nanjing Medlander Medical Technology Co.,Ltd. (SHSE:688273) for CNY 0.332 million on January 14, 2023. Nanjing Reseader Medical Technology Co., Ltd. reported total assets of CNY 10.07 million and net assets of CNY 4.10 million on August 31, 2022. Nanjing Medlander Medical Technology board approved the transaction.
Nanjing Medlander Medical Technology Co.,Ltd.
Equities
688273
CNE100005PV8
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.63 CNY | -2.04% |
|
+3.98% | -38.07% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-38.07% | 281M | |
+7.77% | 218B | |
+10.16% | 189B | |
+26.21% | 151B | |
+32.78% | 113B | |
+1.98% | 64.02B | |
+14.48% | 52.6B | |
+2.92% | 49.85B | |
-6.60% | 37.89B | |
-1.07% | 34.92B |
- Stock Market
- Equities
- 688273 Stock
- News Nanjing Medlander Medical Technology Co.,Ltd.
- Zhu Bisheng agreed to acquire 10% stake in Nanjing Reseader Medical Technology Co., Ltd. from Nanjing Medlander Medical Technology Co.,Ltd. for CNY 0.332 million.